Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP846843.RA5iJ8eEAQAL9PuQgqYj7kFQocd4TMKI5Lqw0WgNynrL4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP846843.RA5iJ8eEAQAL9PuQgqYj7kFQocd4TMKI5Lqw0WgNynrL4130_assertion type Assertion NP846843.RA5iJ8eEAQAL9PuQgqYj7kFQocd4TMKI5Lqw0WgNynrL4130_head.
- NP846843.RA5iJ8eEAQAL9PuQgqYj7kFQocd4TMKI5Lqw0WgNynrL4130_assertion wasGeneratedBy ECO_0000203 NP846843.RA5iJ8eEAQAL9PuQgqYj7kFQocd4TMKI5Lqw0WgNynrL4130_provenance.
- NP846843.RA5iJ8eEAQAL9PuQgqYj7kFQocd4TMKI5Lqw0WgNynrL4130_assertion wasDerivedFrom befree-20150227 NP846843.RA5iJ8eEAQAL9PuQgqYj7kFQocd4TMKI5Lqw0WgNynrL4130_provenance.
- NP846843.RA5iJ8eEAQAL9PuQgqYj7kFQocd4TMKI5Lqw0WgNynrL4130_assertion SIO_000772 20531310 NP846843.RA5iJ8eEAQAL9PuQgqYj7kFQocd4TMKI5Lqw0WgNynrL4130_provenance.
- NP846843.RA5iJ8eEAQAL9PuQgqYj7kFQocd4TMKI5Lqw0WgNynrL4130_assertion evidence source_evidence_literature NP846843.RA5iJ8eEAQAL9PuQgqYj7kFQocd4TMKI5Lqw0WgNynrL4130_provenance.
- NP846843.RA5iJ8eEAQAL9PuQgqYj7kFQocd4TMKI5Lqw0WgNynrL4130_assertion description "[These data indicate that the AGR2 pathway represents a novel pro-oncogenic pathway for evaluation as anti-cancer drug developments, especially therapies that by-pass the agonist effects of tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP846843.RA5iJ8eEAQAL9PuQgqYj7kFQocd4TMKI5Lqw0WgNynrL4130_provenance.